newsfilter
← Latest News
ACCESS Newswire·

Xenetic Biosciences, Inc. Announces Research and Development Collaboration with The Scripps Research Institute to Advance DNase Platform

- Collaboration provides a significant step forward in the advancement of Xenetic's DNase-based oncology program towards Phase 1 clinical development- Systemic DNase program initially targeting multi-billion-dollar